# Quick Reference: Preset Scenarios

## Scenario Comparison (20 total assets, Overall therapeutic area, Base cost)

| Scenario | Ph1 | Ph2 | Ph3 | Expected Approvals | Total Cost ($M) | Cost/Approval ($M) | Timeline (yrs) |
|----------|-----|-----|-----|-------------------|-----------------|-------------------|----------------|
| Balanced Portfolio | 10 | 6 | 4 | 3.85 | 4495.0 | 1168.2 | 6.9 |
| Early-Stage Focus (High Risk) | 14 | 4 | 2 | 2.73 | 4244.6 | 1555.2 | 7.5 |
| Late-Stage Focus (Low Risk) | 4 | 6 | 10 | 6.71 | 4892.1 | 728.7 | 5.6 |
| Barbell Strategy | 10 | 2 | 8 | 5.43 | 4523.8 | 832.8 | 6.3 |
| Speed-to-Market | 2 | 6 | 12 | 7.67 | 5024.4 | 655.2 | 5.1 |


## Key Insights

1. **Late-Stage Focus** yields highest expected approvals (7.67) but at highest cost ($5024.4M)

2. **Early-Stage Focus** has lowest expected approvals (2.73) but longest timeline (7.5 years)

3. **Barbell Strategy** (heavy early + late, minimal mid) represents a bet on avoiding Phase 2 attrition

4. **Risk-Adjusted Return** metric balances approvals against cost and time:
   - Higher = better efficiency
   - Best scenario: Speed-to-Market

## Usage in Shiny App

Users can:
- Select a preset scenario as starting point
- Adjust allocation via sliders
- Compare custom allocation to presets
- See real-time trade-off visualizations

